Search details
1.
Independent origins of fetal liver haematopoietic stem and progenitor cells.
Nature
; 609(7928): 779-784, 2022 09.
Article
in English
| MEDLINE | ID: mdl-36104564
2.
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.
Blood
; 141(8): 917-929, 2023 02 23.
Article
in English
| MEDLINE | ID: mdl-36356299
3.
Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients.
Br J Haematol
; 204(1): 221-228, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37920129
4.
Prognostic factors of idiopathic hypereosinophilic syndrome: A nationwide survey in Japan.
Br J Haematol
; 2024 May 26.
Article
in English
| MEDLINE | ID: mdl-38797527
5.
Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis.
Ann Hematol
; 103(1): 97-103, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37946031
6.
Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Jpn J Clin Oncol
; 54(2): 153-159, 2024 Feb 07.
Article
in English
| MEDLINE | ID: mdl-37986553
7.
Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia.
Clin Exp Nephrol
; 2024 Feb 25.
Article
in English
| MEDLINE | ID: mdl-38402503
8.
Non-driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia.
Eur J Haematol
; 110(2): 131-136, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36208190
9.
Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma.
Mol Ther
; 30(2): 534-549, 2022 02 02.
Article
in English
| MEDLINE | ID: mdl-34628050
10.
Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemia.
J Thromb Thrombolysis
; 55(2): 263-272, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36484956
11.
Diagnosis- and Prognosis-Related Gene Alterations in BCR::ABL1-Negative Myeloproliferative Neoplasms.
Int J Mol Sci
; 24(16)2023 Aug 21.
Article
in English
| MEDLINE | ID: mdl-37629188
12.
von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well-controlled platelet counts.
Eur J Haematol
; 109(6): 779-786, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36130908
13.
SURPASS-ET: phase III study of ropeginterferon alfa-2b versus anagrelide as second-line therapy in essential thrombocythemia.
Future Oncol
; 18(27): 2999-3009, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35924546
14.
A pilot study examining the efficacy of hochuekkito for improving quality of life in patients with myeloproliferative neoplasms.
Jpn J Clin Oncol
; 52(8): 880-886, 2022 08 05.
Article
in English
| MEDLINE | ID: mdl-35575284
15.
Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.
Jpn J Clin Oncol
; 52(1): 29-38, 2022 Jan 03.
Article
in English
| MEDLINE | ID: mdl-34739075
16.
[Systemic chemotherapy combined with thrombopoietin receptor agonist for the treatment of diffuse large B-cell lymphoma complicated with aplastic anemia].
Rinsho Ketsueki
; 63(1): 20-25, 2022.
Article
in Japanese
| MEDLINE | ID: mdl-35135947
17.
Chemotherapy for non-Hodgkin lymphoma in the hemodialysis patient: A comprehensive review.
Cancer Sci
; 112(7): 2607-2624, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33938097
18.
CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome-negative myeloproliferative neoplasms.
Cancer Sci
; 112(2): 884-892, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33280191
19.
Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab.
Blood
; 134(10): 814-825, 2019 09 05.
Article
in English
| MEDLINE | ID: mdl-31270105
20.
Crucial role of hematopoietic JAK2 V617F in the development of aortic aneurysms.
Haematologica
; 106(7): 1910-1922, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-33567809